Table 1. Neurologic complications associated with aging and HIV-1 infection.
Observation | Issues | Ref. |
---|---|---|
Older HIV+ patients display greater neurocognitive impairment |
Utilized large cohorts of HIV+ and HIV− patients, but uninfected control group was younger than HIV+ group |
[116] |
Age effects seen in older HIV+ patients as compared with younger HIV+ patients |
Lacked young and old HIV− control groups |
[127] |
Differential decline in cognitive impairment with increasing age in HIV+ patients |
Sample of older HIV− patients was small |
[128] |
No significant interaction between age and neurocognitive impairment |
None. Well-controlled study using a well-established cohort |
[129] |
Decreased concentrations of N-acetylaspartate in frontal white matter suggest mitochondrial toxicity |
Only looked at four antiretroviral compounds |
[130] |
Cardiovascular diseases, including dyslipidemia, hypertension and diabetes, associated with neurocognitive impairment in HIV+ patients, and greater neurocognitive score |
[114,115,132] | |
Diffusion-weighted MRI found an association between abnormal glucose metabolism and lower fatty acid in caudate nucleus and hippocampus |
Effects were mitigated with age and education adjustment |
[134] |